The Mission Connect Mild TBI Translational Research Consortium

Abstract

In this study we propose to use magnetoencephalography (MEG) to detect and characterize focal abnormalities in neurophysiological function in patients with mTBI and PTSD for the purpose of distinguishing between the two. MEG is a completely non-invasive imaging modality which is able to provide information regarding focal abnormalities in the brain. MEG has been shown to be sensitive to cognitive complaints in patients with mTBI. In addition neurophysiological abnormalities differentiate patients with mTBI and PTSD in some studies. We also propose to explore the relationship between diffusion tensor imaging (DTI) and MEG findings. While MEG provides data regarding focal abnormalities in neural response in the cortex, DTI reveals the status of white matter tracts that form the intracortical connections. Thus, MEG, in combination with DTI, may lead to identification of more distinct, replicable patterns of brain abnormalities in subjects with PTSD and mTBI that may lead to better differentiation between these groups of patients, as well as from patients with a combination of both disorders. We continue to await approval to begin to collect data from patients at this time.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2009
Accession Number
ADA510402

Entities

People

  • Andrew C. Papanicolaou

Organizations

  • University of Texas Health Science Center at Houston

Tags

DTIC Thesaurus Topics

  • Abnormalities
  • Abstracts
  • Biomedical Research
  • Consortiums
  • Contract Administration
  • Contracts
  • Craniocerebral Trauma
  • Data Management
  • Department Of Defense
  • Diffusion
  • Diseases And Disorders
  • Head Injuries
  • Information Operations
  • Magnetoencephalography
  • Neuroimaging
  • Universities

Fields of Study

  • Medicine

Readers

  • Allergy and Immunology.
  • Molecular and genetic basis of cancer.
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.